Inretail Peru Corp. · BVL:INRETC1
Inretail Peru — Q4 2024 Earnings Presentation
19 slides from Inretail Peru's earnings presentation, February 2025
Slide 1: 2024 Earnings Presentation Q4'24 & FY 2024
2024 EARNINGS PRESENTATION Q4’24 & FY 2024
Slide 2: Agenda
AGENDA Q4’24 2024 01 CONSOLIDATED RESULTS FINANCIAL 02 2024 HIGHLIGHTS 03 RESULTS BY SEGMENT 04 OTHER FINANCIAL RESULTS
Slide 3: Consolidated Financial Results
2024 01 CONSOLIDATED FINANCIAL RESULTS
Slide 4: Q4'24 & FY'24 Results – Consolidated
Q4’24 & FY’24 RESULTS – CONSOLIDATED Million Soles (S/ mm) Highlights Revenues +3.9% Solid growth in Revenues, with a double-digit growth in our Food Retail segment, a high single-digit growth in our Shopping Malls 21,683 segment and a moderate growth in our Pharma segment 20,863 Strong double-d
Slide 5: FY'24 – Consolidated Financial Results
FY’24 – CONSOLIDATED FINANCIAL RESULTS Food Shopping Pharma Retail Malls 1/ 2024 (S/ mm; %) + + = Revenues 12,137 8,810 812 21,683 % Revenues Contribution 56% 40% 4% Adj. EBITDA2/ 1,155 1,473 501 3,003 % Adj. EBITDA Contribution 37% 47% 16% Adj. EBITDA Margin3/ 9.5% 16.7% 82.6% 13.9% _ Market Positi
Slide 6: 2024 Highlights
2024 2024 HIGHLIGHTS 2 InRetail
Slide 7: 2024 Highlights
2024 HIGHLIGHTS Diversified and resilient Continued executing our expansion and Strengthened our business models multi-format strategies omnichannel platform • Moderate growth in Revenues and solid growth in • Opened 367 Mass stores, reaching 1,250 • Strong growth in our Food and Pharmacies Adjusted
Slide 8: 2024 Highlights – ESG
2024 HIGHLIGHTS – ESG 4th consecutive year as +18 mm Our Pharma and Food Retail members of S&P DJSI MILA Rations of food donated businesses received the 3rd and Yearbook Member star of the “Formación Dual” Ministry of Ranked 5th among the best companies +S/70 mm +90k participants Environment in the
Slide 9: Results by Segment
RESULTS BY SEGMENT 2 InRetail
Slide 10: Q4'24 Results – Food Retail
Q4’24 RESULTS – FOOD RETAIL1/ Million Soles (S/ mm) S/ mm Q4'24 Q4'23 Var % 2024 Var % Revenues 3,451 3,120 10.6% 12,137 6.7% Gross Profit 810 754 7.4% 2,851 5.7% 2/ 348 328 6.2% 1,155 3.9% Adj. EBITDA Gross Mg 23.5% 24.2% -70 bps 23.5% -22 bps 2/ 10.1% 10.5% -42 bps 9.5% -25 bps Adj. EBITDA Mg Reve
Slide 11: Q4'24 Results – Pharma
Q4’24 RESULTS – PHARMA Million Soles (S/ mm) S/ mm Q4'24 Q4'23 Var % 2024 Var % Revenues 2,206 2,151 2.5% 8,810 0.2% Gross Profit 734 677 8.5% 2,874 3.7% 1/ 385 321 20.1% 1,473 8.0% Adj. EBITDA Gross Mg 33.3% 31.5% 182 bps 32.6% 110 bps 1/ 17.5% 14.9% 255 bps 16.7% 121 bps Adj. EBITDA Mg Revenues in
Slide 12: Q4'24 Results – Shopping Malls
Q4’24 RESULTS – SHOPPING MALLS Million Soles (S/ mm) S/ mm Q4'24 Q4'23 Var % 2024 Var % Revenues 223 207 7.8% 812 6.5% Gross Profit 148 135 10.3% 541 8.5% 1/ 137 121 12.6% 501 9.2% Adj. EBITDA Gross Mg 66.6% 65.1% 150 bps 66.6% 120 bps 2/ 82.4% 80.3% 211 bps 82.6% 66 bps Net Rental Mg Revenues reach
Slide 13: Quarterly Openings and SSS by Segment
QUARTERLY OPENINGS AND SSS BY SEGMENT Openings Same Store Sales (SSS) Food Retail1/ Food Retail1/ 2023: 3.4% Sales Area (‘000 sqm) 2024: 2.5% 636 675 591 601 622 2/ 236 5.3% 157 167 188 202 3.2% 2.8% 115 115 115 115 120 1.4% 2/ 319 319 319 319 319 Q4’23 Q1’24 Q2’24 Q3’24 Q4’24 -1.8% Hard Discount 90
Slide 14: Other Financial Results
2024 04 OTHER FINANCIAL RESULTS
Slide 15: Consolidated Net Income
CONSOLIDATED NET INCOME Million Soles (S/ mm) Net Income1/ Net Income Breakdown1/ +3.8% -40 +96 971 322 -54 936 -3 293 -37 +10 -8.8% 322 293 Q4’23 Q4’24 2023 2024 Net 5.9% 5.0% 4.5% 4.5% Net Income Adj. Net FX Mark to Higher Higher Lower Tax Net Income Margin Q4’23 EBITDA Effect Market Financial D&A
Slide 16: Capex and Cash-Flow Breakdown
CAPEX AND CASH-FLOW BREAKDOWN Million Soles (S/ mm) Consolidated CAPEX 2023: S/775 mm 2024: S/1,041 mm 1,041 847 679 369 384 294 231 228 216 197 137 129 2019 2020 2021 20221/ Q1’23 Q2’23 Q3’23 Q4’23 Q1’24 Q2’24 Q3’24 Q4’24 Cash-Flow Breakdown -1,041 -237 +2,799 -530 1,461 1,142 3/ -410 1982/ -330 33
Slide 17: Consolidated Financial Debt
CONSOLIDATED FINANCIAL DEBT Million Soles (S/ mm) Consolidated Financial Debt1/ USD Exposure on Financial Debt Net Debt/Adj.EBITDA Debt/Adj.EBITDA Hedge USD PEN 2.7x 2.7x 2.7x 2.6x 2.4x 2.3x 2.3x 2.3x 50% 49% 49% 49% 51% 2.2x 1.9x 1% 1% 2% 1% 2% 49% 50% 50% 50% 48% 2023 LTM Q1’24 LTM Q2’24 LTM Q3’24
Slide 18: Financial Debt by Segment
FINANCIAL DEBT BY SEGMENT1/ Million Soles (S/ mm) Net Debt/Adj. EBITDA Debt/Adj. EBITDA Total Consolidated Debt: S/7,341 mm Debt / Adj. EBITDA: 2.4x Net Debt / Adj. EBITDA: 1.9x Debt / Adj. EBITDA: 2.1x Net Debt / Adj. EBITDA: 1.7x 4.3x 4.2x 4.1x 4.0x 3.9x 2.8x 2.9x 2.9x 2.9x 1.8x 1.8x 1.7x 1.7x 2.6
Slide 19: Contact Information
CONTACT INFORMATION Andrea Fabbri Investor Relations Officer IR email: ir@inretail.pe This material was prepared solely for informational purposes and is not to be construed as a solicitation or an offer to buy or sell any securities. This presentation may include forward-looking statements or state